1. Bar-Shalom, A., & Cook-Deegan, R. (2002). Patents and innovation in cancer therapeutics: Lessons from CellPro. The Milbank Quaterly, 80(4), 637–676.
2. Bartenbach, K., Jung, I., & Renvert, A. (2013). Apple vs. Samsung – Zu den Grenzen von Geschmacksmusterschutz und ergänzendem wettbewerbsrechtlichen Leistungsschutz. Mitteilungen der deutschen Patentanwälte, 104(1), 18–24.
3. Cohen, W. M., Nelson, R. R., & Walsh, J. P. (2000). Protecting their intellectual assets: Approbability conditions and why US manufacturing firms patent or not. NBER working paper, Nr. 7552.
4. Corrado, C., Haskel, J., Jona-Lasinio, C., & Iommi, M. (2012). Intangible capital and growth in advanced economies: Measurement methods and comparative results. IZA discussion paper, Nr. 6733.
5. Deng, Z., Lev, B., & Narin, F. (1999). Science & technology as predictors of stock performance. Financial Analysts Journal, 55(5), 20–32.